Hainan Shuangcheng Pharmaceuticals Co., Ltd.



Quote for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002693
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002693 quote

Summary for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Hainan Shuangcheng Pharmaceuticals Co., Ltd. is principally engaged in the research, development, manufacture and distribution of chemical polypeptide drugs. The Company provides chemical polypeptide, including thymalfasin, somatostatin and thymopentin for injection; antibiotics, including azitromycin and clindamycin hydrochloride for injection; drugs for cardio-cerebrovascular diseases, including sodium ferulate, adenosine cyclophosphate, tetramethylpyrazine phosphate, inosine and ozagrel sodium for injection, as well as drugs for gastrointestinal disorders, anti-virus drugs, urinary system drugs and anti-tumor drugs, among others.

Profile for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Full Name:Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Full Name in Chinese:海南双成药业股份有限公司 Short Name in Chinese:双成药业
Symbol/Stock Code:
002693
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Wang Chengdong
Secretary of the Board:
Yu Xiaofeng
Phone:
+86-898-68592978
Fax:
+86-898-68592978
Official Website:www.shuangchengmed.com
E-mail:yuxiaofeng@shuangchengmed.com
Address:No. 16 Xingguo Road, Xiuying Dis,HAIKOU HAN 570311
IPO Subscription Date:
2012-07-31
Listing Date:
2012-08-08
IPO Issued Capital:
30000000
IPO Price:
20
IPO fees:
50380300 CNY
Money Raised by IPO:
600000000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
549619700 CNY
Open(Listing day):
- CNY
Close(Listing day):
- CNY
Diluted P/E ratio after IPO:
35.0900
Turnover rate(listing day):
-%

Financials for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

UPDATE:2012-10-26 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
46.3736
70.4119
64.2296
32.1071
Net Profit Growth(%)
10.11
9.62
100.04
-
Return On Equity(ROE)(%)
5.62
30.85
40.70
41.19
Debt ratio(%)
4.12
7.99
37.55
20.34
Net Operating Cash Flow/Net Profit(%)
110.54
93.81
86.14
137.87

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.5000
0.7800
0.7100
0.3567
Diluted Earnings Per Share
0.0000
0.7600
0.7100
0.0000
Net Asset Value Per Share (NAVPS)
6.8700
2.5400
1.7500
0.8661
Additional Paid-In Capital Per Share
4.7627
0.5767
0.5767
0.0111
Retained Earnings Per Share
1.0371
0.8633
0.1589
0.7309
Net Cash Flow From Operatings Activities Per Share
0.4300
0.7300
0.6100
0.4919
Net Cash Flow Per Share
4.6271
-1.2916
1.5545
0.0531

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
860.0891
248.0576
252.7345
97.8531
Total Liabilities(Million)
35.4879
19.827
94.9159
19.907
Current Liabilities(Million)
19.6279
17.727
93.1159
18.107
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
588.8431
33.5878
149.8314
9.929
Accounts Receivables(Million)
4.968
3.184
2.593
4.212
Deposit Received(Million)
1.3161
1.0365
4.2269
1.8941
Other Receivables(Million)
0.3268
0.7561
2.4868
4.2822
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
824.6011
228.2306
157.8186
77.9461
Debt ratio(%)
4.12
7.99
37.55
20.34
Equity Ratio(%)
95.8700
92.0000
62.4400
79.6500
Current Ratio
33.8235
5.3864
1.9506
1.7572
Quick Ratio
32.8341
4.6977
1.8391
1.2176

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
106.4278
142.3943
131.2512
104.2253
Net Cash Flow From Operatings Activities(Million)
51.2621
66.0534
55.3298
44.2674
Net Cash Flow From Operatings Activities Change(%)
82.09
19.38
24.99
-
Net Cash Flow(Million)
555.2553
-116.2436
139.9024
4.7758
Cash From Selling Commodities/Prime Revenue(%)
119.57
106.66
116.28
118.19
Net Cash Flow/Net Profit(%)
1197.35
-165.09
217.82
14.87
Cash Flow From Investing Activities(Million)
-51.0068
-107.1455
-9.1515
-23.2138
Cash Flow From Financing Activities(Million)
555
-75.0855
93.7241
-16.2778

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
89.0063
133.5033
112.8772
88.183
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
3.9368
5.4695
5.3453
11.4591
Administrative Costs(Million)
10.0389
16.9054
9.4744
9.2434
Financing Costs(Million)
-2.8286
-1.5436
-0.2477
0.262
Above Three Costs Change(%)
1.02
42.95
-30.49
-
Operating Profit(Million)
50.8085
77.9434
71.5458
38.7487
Income From Investment(Million)
-
-
1.358
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
3.7808
2.0735
0.6151
-2.8556
Total Profit(Million)
54.5893
80.0169
72.1609
35.8932
Corporate Income Tax(Million)
8.2158
9.605
7.9313
3.7861
Net Profit(Million)
46.3736
70.4119
64.2296
32.1071
Gross Profit Ratio(%)
70.39
74.76
74.88
67.18
Operating Margin(%)
57.08
58.38
63.38
43.94
Return On Equity(ROE)(%)
5.62
30.85
40.70
41.19

Announcements for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Date: 2012-10-31
Title: EGM RESOLUTION
The Company held its 4th Extraordinary General Meeting of 2012 on 30 October 2012, during which the following proposal(s) was/were approved:
1. To purchase bank financing products with self-possessed funds
2. Amendments to the Company's articles of association
3. Formulation of shareholder return plan for the next three years from 2012 to 2014
Date: 2012-10-15
Title: EGM-ONLINE
The Company will hold the 4th Extraordinary General Meeting of 2012 at 14:50 on 30 October 2012.

Meeting agenda:
1. To purchase bank financing products with self-possessed funds
2. Amendments to the Company's articles of association
3. Formulation of shareholder return plan for the next three years from 2012 to 2014


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 25 October 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: from 26 October 2012 to 29 October 2012

The Company's shareholder may choose to vote online via the trading system of Shenzhen Stock Exchange or via the website of http://wltp.cninfo.com.cn.
Part I Voting via the trading system
Voting date: 30 October 2012
Voting code:362693
Voting abbreviation:Shuangcheng Pharmaceuticals voting
Voting process:
1. To input the "buy" instruction to begin voting
2. To input the serial number of the Investors Meeting proposals under the item of "subscription price" "1 share" for voting for, "2 shares" for voting against and "3 shares" for "abstention".

Part II Voting via the internet
Shareholders may choose the CA (certification authority) or service password for identity verification. As to the service password, shareholders may apply for a password on the website http://www.szse.cn or http://wltp.cninfo.com.cn.
Voting period: from 29 October 2012 to 30 October 2012.
Date: 2012-10-12
Title: EGM RESOLUTION
The Company held its 3rd Extraordinary General Meeting of 2012 on 11 October 2012, during which the following proposal(s) was/were approved:
1. Implementation rules for online voting
Date: 2012-09-07
Title: EGM RESOLUTION
The Company held its 2nd Extraordinary General Meeting of 2012 on 06 September 2012, during which the following proposal(s) was/were approved:
1. Amendments to the Company's articles of association
Date: 2012-08-22
Title: EGM-SPOT
The Company will hold the 2nd Extraordinary General Meeting of 2012 at 10:00 on 06 September 2012.

Meeting agenda:
1. Amendments to the Company's articles of association


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 03 September 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: from 04 September 2012 to 05 September 2012
Date: 2012-08-07
Title: IPO SHARE LISTING
The Company's 30 million shares (code:002693) in its initial public offering will be listed on the Shenzhen Stock Exchange on 08 August 2012.
Date: 2012-07-30
Title: IPO-ONLINE SUBSCRIPTION
Hainan Shuangcheng Pharmaceuticals Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSRC) to issue 30.000000 million A-shares in its initial public offering.
1. Class: A shares
2. Stock code: 002693
3. Stock abbreviation: Shuangcheng Pharmaceuticals
4. Issuing volume: 30.000000 million shares
5. Par value: CNY1.00 per share
6. Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
7. Targeted listing bourse: Shenzhen Stock Exchange
8. Offline placement volume: 15.000000 million shares
9. Online offering volume: 15.000000 million shares
10. Price: CNY20.00 per share
11. Offline subscription period: 31 July 2012
12. Online subscription date: 31 July 2012.
Date: 2012-07-24
Title: IPO
Hainan Shuangcheng Pharmaceuticals Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSCR) to issue 30.0000 million A-shares in its initial public offering, which is structured as follows:
1.Class: A shares
2.Size: 30.0000 million shares
3.Par value: CNY1.00 per share
4.Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
5.Targeted listing bourse: Shenzhen Stock Exchange
6.Offline placement volume: 15.0000 million shares
7.Online offering volume:15.0000 million shares
8.IPO price inquiry period: from 24 July 2012 to 26 July 2012
9.IPO price determined: 30 July 2012
10.Offline subscription date:31 July 2012
11.Online subscription date: 31 July 2012
12.Expected listing date:N/A.